Frontiers in fungal biology最新文献

Pest ants are known for their damage to biodiversity, harm to agriculture, and negative impact on human welfare. Ants thrive when environmental opportunities arise, becoming pests and/or invading non-native areas. As social insects, they are extremely difficult to control using sustainable methods like biological control. The latter, although safer to the environment, acts slowly allowing the ants to use their individual and social defenses. Among biocontrol agents, fungal pathogens were proposed as promising, however, it is difficult to ascertain their success when the bibliography has not been reviewed and condensed. Therefore, this paper is the first in performing such task by analyzing publications mainly from 2000 to 2022 about the control of pest ants by fungi. From 85 publications selected, 77% corresponded to laboratory studies. Beauveria and Metarhizium were the genera most used in laboratory and field studies. Most of them included Acromyrmex and Atta leaf-cutter ants (LCA), and Solenopsis fire ants. From laboratory experiments, we evaluated how ant net mortality was affected by ant and fungal species, and also by origin, concentration, and inoculation technique of the fungal strains tested. Beauveria bassiana and Metarhizium anisopliae produced the greatest mortality, along with the inoculation spray technique and fungal strains collected from ants. There was a positive relationship between ant mortality and fungal concentration only for those studies which evaluated more than one concentration. Twenty field experimental studies were found, covering 13 pest species, mainly LCA and Solenopsis invicta. Only B. bassiana was tested on Solenopsis, M. anisopliae was mostly used for Acromyrmex, and M. anisopliae or Trichoderma were mainly used with Atta species. The median control field efficiency varied from 20% to 85% for different fungi and ant genera. When grouping all fungal species together, the median control efficiency seemed to be better for Acromyrmex (67%) than for Atta and Solenopsis (both 43%). Our review shows that, at this stage of knowledge, it is very difficult to extrapolate any result. We offer suggestions to improve and standardize laboratory and field experimental studies in order to advance more efficiently in the fungal control of pest ants.

Associations between fungi and ants living in mutualistic relationship with plants ("plant-ants") have been known for a long time. However, only in recent years has the mutualistic nature, frequency, and geographical extent of associations between tropical arboreal ants with fungi of the ascomycete order Chaetothyriales and Capnodiales (belonging to the so-called "Black Fungi") become clear. Two groups of arboreal ants displaying different nesting strategies are associated with ascomycete fungi: carton-building ants that construct nest walls and galleries on stems, branches or below leaves which are overgrown by fungal hyphae, and plant-ants that make their nests inside living plants (myrmecophytes) in plant provided cavities (domatia) where ants cultivate fungi in small delimited "patches". In this review we summarize the current knowledge about these unsuspected plant-ant-fungus interactions. The data suggest, that at least some of these ant-associated fungi seem to have coevolved with ants over a long period of time and have developed specific adaptations to this lifestyle.

[This corrects the article DOI: 10.3389/ffunb.2022.1062444.].

In fungal pathogens the cell wall plays an important role in host-pathogen interactions because its molecular components (e.g., polysaccharides and proteins) may trigger immune responses during infection. GPI-anchored proteins represent the main protein class in the fungal cell wall where they can perform several functions, such as cell wall remodeling and adhesion to host tissues. Genomic analysis has identified the complement of GPI-anchored proteins in many fungal pathogens, but the function has remained unknown for most of them. Here, we conducted an RNA expression analysis of GPI-anchored proteins of Paracoccidioides brasiliensis which causes paracoccidioidomycosis (PCM), an important human systemic mycosis endemic in Latin America. The expression of the GPI-anchored proteins was analyzed by quantitative PCR in both the mycelium and yeast forms. qPCR analysis revealed that the transcript levels of 22 of them were increased in hyphae and 10 in yeasts, respectively, while 14 did not show any significant difference in either form. Furthermore, we cloned 46 open reading frames and purified their corresponding GPI-anchored proteins in the budding yeast. Immunoblot and ELISA analysis of four purified GPI-anchored proteins revealed immune reactivity of these proteins against sera obtained from PCM patients. The information obtained in this study provides valuable information about the expression of many GPI-anchored proteins of unknown function. In addition, based on our immune analysis, some GPI-anchored proteins are expressed during infection and therefore, they might serve as good candidates for the development of new diagnostic methods.

Compared with antibiotics for treating bacterial infections, there are a limited number of antifungal agents. This is due to several factors, including the difficulties of identifying suitable antifungals that target the fungal cell without damaging host cells, and the reduced rates of diagnosis of fungal infections compared with those caused by bacteria. The problem of treating fungal infections is exacerbated by an increasing incidence of antifungal resistance among human fungal pathogens. Three XF drugs (XF-73, XF-70, and DPD-207) have previously displayed innate bactericidal effects and a low propensity for microbial resistance, with XF-73 and XF-70 having a second, light-activated mechanism of action [known as photodynamic therapy (PDT)]. In an effort to expand the repertoire of antifungal agents, this research assessed the in vitro activity of XF drugs via both mechanisms of action against six strains of the fungal pathogen Candida albicans in both planktonic and biofilm cultures. In addition, this research examined the effects of XF drug treatment on biofilms of C. albicans in a reconstituted human oral epithelium model. All C. albicans strains tested were susceptible to XF-73 and XF-70, with minimum inhibitory concentrations (MICs) between 0.25 µg/mL and 2 µg/mL; DPD-207 was less potent, with MICs between 4 µg/mL and 16 µg/mL, and light activation did not enhance these MICs. Complete biofilm eradication was not reported at the tested XF drug concentrations. However, live and dead staining of C. albicans cells in biofilms after XF drug treatment demonstrated that XF-73 and XF-70 were active against most Candida biofilms tested from 64 µg/mL; again, light activation did not enhance anti-biofilm activity. Candida biofilms were more resistant to DPD-207, with fungicidal effects occurring from 256 µg/mL. XF-73 and XF-70 reduced penetration of C. albicans biofilm into reconstituted human oral epithelium (RHOE) and resulted in less damage (as determined by reduced lactate dehydrogenase release) than untreated biofilms. Overall, the results highlight the potential of XF drugs as new drugs for the management of topical infections caused by C. albicans. Further studies are warranted on the development of XF drugs as antifungals, particularly for XF-73 and XF-70.